Wipro, Dr. Reddy's, Hero MotoCorp in spotlight

Wipro is slated to announce its Q4 numbers today, 15 April 2020.

Dr. Reddy's Laboratories, along with its subsidiaries today announced the launch of authorized generic version of NitroDur (nitroglycerin) Transdermal Infusion System. The combined market for all Nitrogylcerin Transdermal Patch products had U.S. sales of approximately $14.7 million MAT for the most recent twelve months ending in January 2020 according to IQVIA Health.

Separately, Dr. Reddy's Laboratories along with its subsidiaries announced the launch of Amphetamine Sulfate Tablets USP, a therapeutic equivalent generic version of Evekeo (amphetamine sulfate) Tablets approved by the U.S. Food and Drug Administration (USFDA). Amphetamine Sulfate Tablets, USP is a Schedule II drug.

Ind-Ra said it continues to take a consolidated view of M&M and its subsidiaries while arriving at the ratings, after excluding its financial services subsidiary, Mahindra & Mahindra Financial Services (MMFSL; 'IND AAA'/Stable), because of moderate strategic, operational and legal linkages among them.

Hero MotoCorp said that in view of the directives issued by the Central Government relating to the extension of the countrywide lockdown until May 3rd, and the need to keep maintaining social distancing, operations at our manufacturing facilities in India will continue to remain suspended till further notice.

HCL Technologies announced the general availability (GA) of HCL Domino Volt, a new low-code capability built on the HCL Domino platform. HCL Technologies said that this release continues HCL's commitment to transform over 10 million enterprise-grade apps powering business for more than 15,000 customers. Domino Volt is powered by Domino. Domino has always been a leader in application development, business transformation, and automation.

Biocon and Mylan N.V. on 14 April 2020 announced the launch of Fulphila, a biosimilar to Neulasta (pegfilgrastim), in Australia. Fulphila is approved by the therapeutic goods administration for the treatment of cancer patients following chemotherapy, to decrease the duration of severe neutropenia and so reduce the incidence of infections, as manifested by febrile neutropenia.

Apollo Tyres on Tuesday (14 April) announced that its board will meet on 17 April 2020 to consider issuing non-convertible debentures (NCDs) through private placement.

Nectar Lifesciences on Tuesday, 14 April 2020, announced that it has started limited operations of its API (active pharmaceutical ingredient) plants in Derabassi, Punjab. The company, however, said that its plants in Baddi, Himachal Pradesh are still inoperational due to lack of manpower and logistics issues.

Mishra Dhatu Nigam (MIDHANI) on Tuesday (14 April) said its value of production (VoP) rose 21% to Rs 985 crore in the year ended March 2020 (FY20) compared with Rs 814.83 crore in the year ended March 2019 (FY19).

Powered by Capital Market - Live News